2. Signaling Pathways
  3. Others
  4. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (10876):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-66011BS
    (Rac)-Moxifloxacin-d4
    (Rac)-Moxifloxacin-d4 ((Rac)-BAY 12-8039-d4 (free base)) is deuterium labeled (Rac)-Moxifloxacin. (Rac)-Moxifloxacin ((Rac)-BAY 12-8039 free base) is the isoform of Moxifloxacin Hydrochloride (HY-66011), which is an oral 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia.
    (Rac)-Moxifloxacin-d<sub>4</sub>
  • HY-B0089S
    Acarbose-d4
    Acarbose-d4 (BAY g 5421-d4) is deuterium labeled Acarbose. Acarbose (BAY g 5421), antihyperglycemic agent, is an orally active alpha-glucosidase inhibitor (IC50=11 nM). Acarbose can potentiate the hypoglycemic effects of sulfonylureas or insulin.
    Acarbose-d<sub>4</sub>
  • HY-W024104S
    2-(4-Fluorophenyl)pyridine-d8
    2-(4-Fluorophenyl)pyridine-d8 is the deuterium labeled 2-(4-Fluorophenyl)pyridine (HY-W024104).
    2-(4-Fluorophenyl)pyridine-d<sub>8</sub>
  • HY-127090S
    Muramyl dipeptide-d3
    Muramyl dipeptide-d3 (MDP-d3) is the deuterium labeled Muramyl dipeptide. Muramyl dipeptide (MDP) is a synthetic immunoreactive peptide, consisting of N-acetyl muramic acid attached to a short amino acid chain of L-Ala-D-isoGln. Muramyl dipeptide is an inducer of bone formation through induction of Runx2. Muramyl dipeptide directly enhances osteoblast differentiation by up-regulating Runx2 gene expression through MAPK pathways. Muramyl dipeptide is a NLRP1 agonist .
    Muramyl dipeptide-d<sub>3</sub>
  • HY-146898S
    1-Desoxymethylsphinganine-d5
    		99%
    1-Desoxymethylsphinganine-d5 is deuterium labeled 1-Desoxymethylsphinganine.
    1-Desoxymethylsphinganine-d<sub>5</sub>
  • HY-W653875
    Azithromycin-d5
    Azithromycin-d5 (CP-62993-d5) is the deuterium labeled Azithromycin (CP-62993) (HY-17506). Azithromycin is a macrolide antibiotic useful for thestudy of a number of bacterial infections.
    Azithromycin-d<sub>5</sub>
  • HY-128417S4
    alpha-D-glucose13C6
    alpha-D-glucose-13C6 is 13C-labeled alpha-D-glucose (HY-128417). alpha-D-glucose is an endogenous metabolite.
    alpha-D-glucose<sup>13</sup>C<sub>6</sub>
  • HY-145399S
    AZ14170133-d5
    AZ14170133-d5 (SG 3932-d5) is the deuterium labeled AZ14170133 (HY-145399). AZ14170133 (SG 3932) is a Drug-Linker Conjugates for ADC, which comprises a topoisomerase inhibitor and a linker for ligand unit connecting. AZ14170133 can be used to synthesis antibody-drug conjugate (ADC).
    AZ14170133-d<sub>5</sub>
  • HY-W145492S3
    D-(+)-Talose-13C-1
    		99.0%
    D-(+)-Talose-13C-1 is the 13C labeled D-(+)-Talose.
    D-(+)-Talose-<sup>13</sup>C-1
  • HY-154814S
    Monohydroxy-3-butenyl-mercapturic acid-13C2,15N sodium
    Monohydroxy-3-butenyl-mercapturic acid-13C3,15N sodium is 15N and 13C labeled Monohydroxy-3-butenyl-mercapturic acid.
    Monohydroxy-3-butenyl-mercapturic acid-<sup>13</sup>C<sub>2</sub>,<sup>15</sup>N sodium
  • HY-113113S
    13,14-Dihydro PGE1-d4
    13,14-Dihydro PGE1-d4 (13,14-Dihydroprostaglandin E1-d4) is deuterium labeled 13,14-Dihydro PGE1. 13,14-Dihydro PGE1 is a metabolite of PGE1 (Prostaglandin E1) which inhibits the ADP-induced platelet aggregation (ID50 = 10.8 ng/mL platelet rich plasma).
    13,14-Dihydro PGE1-d<sub>4</sub>
  • HY-W742358
    4'-Hydroxy pyrimethanil-d4
    4'-Hydroxy pyrimethanil-d4 is the deuterium labeled 4'-Hydroxy pyrimethanil.
    4'-Hydroxy pyrimethanil-d<sub>4</sub>
  • HY-129254S
    5-Hydroxy propranolol-d5
    5-Hydroxy Propranolol-d5 is the deuterium labeled 5-Hydroxy Propranolol.
    5-Hydroxy propranolol-d<sub>5</sub
  • HY-W748328
    Ixazomib-13C2,15N
    Ixazomib-13C2,15N is 13C and 15N labeled Ixazomib. Ixazomib (MLN2238) is a selective, potent, and reversible proteasome inhibitor, which inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome with an IC50 of 3.4 nM (Ki of 0.93 nM).
    Ixazomib-<sup>13</sup>C<sub>2</sub>,<sup>15</sup>N
  • HY-N7101S1
    Cefpodoxime Proxetil-d6
    Cefpodoxime Proxetil-d6 (U-76,252-d6) is deuterium labeled Cefpodoxime Proxetil. Cefpodoxime proxetil is an orally administered broad spectrum third-generation cephalosporin. Cefpodoxime proxetil has anti-bacterial activity. Cefpodoxime proxetil binds to penicillin binding proteins (PBPs) which inhibits peptidoglycan synthesis, finally results in interfering bacterial cell wall biosynthesis.
    Cefpodoxime Proxetil-d<sub>6</sub>
  • HY-10977S
    Tivozanib-d6
    Tivozanib-d6 (AV-951-d6) is deuterium labeled Tivozanib. Tivozanib (AV-951; KRN951) is a selective, orally active inhibitor for vascular endothelial growth factor receptor (VEGFR)-1, 2 3, with IC50s of 30, 6.5 and 15 nM, respectively. Tivozanib exhibits antitumor efficacy.
    Tivozanib-d<sub>6</sub>
  • HY-W722239
    Methyl 2-methylbutyrate-d3
    Methyl 2-methylbutyrate-d3 is deuterated labeled Methyl 2-methylbutyrate.
    Methyl 2-methylbutyrate-d<sub>3</sub>
  • HY-154781S
    Hydroxycerivastatin-d3 sodium
    Hydroxycerivastatin-d3 sodium is deuterated labeled Hydroxycerivastatin.
    Hydroxycerivastatin-d<sub>3</sub> sodium
  • HY-40354S5
    Tofacitinib-d3
    Tofacitinib-d3 (Tasocitinib-d3) is deuterium labeled Tofacitinib. Tofacitinib is an orally available JAK3/2/1 inhibitor with IC50s of 1, 20, and 112 nM, respectively.
    Tofacitinib-d<sub>3</sub>
  • HY-165690
    N,N-Dimethylaminosulfonic acid-d3
    N,N-Dimethylaminosulfonic acid-d3 (Dimethylsulfamic acid-d3) is deuterium labeled N,N-Dimethylaminosulfonic acid.
    N,N-Dimethylaminosulfonic acid-d<sub>3</sub>